Anzeige
Mehr »
Login
Sonntag, 09.03.2025 Börsentäglich über 12.000 News von 690 internationalen Medien
Pioneer AI und StreaksAI revolutionieren den $28,5-Milliarden-Markt für autonome KI mit AROK
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CS50 | ISIN: BE0974386188 | Ticker-Symbol: 86C
Frankfurt
07.03.25
08:20 Uhr
2,910 Euro
-0,020
-0,68 %
Branche
Chemie
Aktienmarkt
Sonstige
1-Jahres-Chart
BIOTALYS NV Chart 1 Jahr
5-Tage-Chart
BIOTALYS NV 5-Tage-Chart
RealtimeGeldBriefZeit
3,0003,10008.03.
GlobeNewswire (Europe)
232 Leser
Artikel bewerten:
(1)

Biotalys NV: Information on the total number of voting rights and shares

Finanznachrichten News

Regulated Information

Ghent, BELGIUM, Jan. 27, 2025(hereafter the "Company" or "Biotalys"), an Agricultural Technology (AgTech) company developing protein-based biocontrol solutions for crop protection, today announces in accordance with article 15 of the Belgian Act of 2 May 2007 on the disclosure of major shareholdings (the "Belgian Act"), that the outstanding share capital and outstanding voting securities of the Company can be summarised as follows:

  • Share capital: EUR 5,540,603.84 EUR
  • Total number of securities carrying voting rights: 37,470,062 (all ordinary shares)
  • Total number of voting rights (= denominator): 37,470,062 (all relating to ordinary shares)
  • Number of rights to subscribe for securities carrying voting rights not yet issued:
    • 1,964,400 "ESOP Warrants", entitling their holders to subscribe for a total number of 1,964,400 profit certificates which will, if and when issued, automatically convert into a total number of maximum 982,200 securities carrying voting rights (all ordinary shares).
    • 1,130,397 "ESOP Warrants", entitling their holders to subscribe for a total number of maximum 1,130,397 securities carrying voting rights (all ordinary shares).
    • 23,926 share units, awarded in aggregate to the independent directors of the Company in the framework of its remuneration policy. Each share unit contains the obligation to subscribe to one new share of the Company at an issue price of one EUR per share-unit. Cash settlement is possible. The conditions of the share units are described in the remuneration policy of the Company.
  • The Company has no outstanding convertible bonds or non-voting shares.

Pursuant to the Belgian Act, a notification to the Company and the Belgian Financial Services and Markets Authority (FSMA) is required by all natural and legal persons in each case where the percentage of voting rights attached to the securities held by such persons in the Company reaches, exceeds or falls below the threshold of 5%, 10%, and every subsequent multiple of 5%, of the total number of voting rights in the Company.

For further information, please contact:

Toon Musschoot, Head of IR & Communication
T: +32

About Biotalys

Biotalys is an Agricultural Technology.

Attachments

  • Biotalys Press Release Regulated Information_27 January 2025 (https://ml.globenewswire.com/Resource/Download/dbaf0fa5-c837-449e-98d2-0e482ebc42c1)
  • Biotalys Persbericht Gereglementeerde Informatie_27 januari 2025 (https://ml.globenewswire.com/Resource/Download/1b926fee-f28f-414d-83ac-0daa06d1febb)

© 2025 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.